US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Obstetrics/Gynecology Market Research Reports & Industry Analysis

RSS Feeds

Obstetrics/Gynecology Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Midwives: State Industry Market Evaluator 621399.08
12/1/2014 | published by: BizMiner
... for 2011-2012-2013-2014q2 for these measures: industry market volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, ...  |  read more...
USD 599
Abortion Information & Services: State Industry Market Evaluator 621410.01
12/1/2014 | published by: BizMiner
... Statistics are displayed for 2011-2012-2013-2014q2 for these measures: industry market volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include ...  |  read more...
USD 599
Post Menopausal Osteoporosis-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Post Menopausal Osteoporosis. This report provides information on the therapeutic development based on the Post Menopausal Osteoporosis dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Premenstrual Syndrome-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Premenstrual Syndrome. This report provides information on the therapeutic development based on the Premenstrual Syndrome dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Primary Dysmenorrhea-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Primary Dysmenorrhea. This report provides information on the therapeutic development based on the Primary Dysmenorrhea dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Uterine Cancer-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Uterine Cancer. This report provides information on the therapeutic development based on the Uterine Cancer dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Uterine Fibroids-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Uterine Fibroids. This report provides information on the therapeutic development based on the Uterine Fibroids dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Vaginitis -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Vaginitis . This report provides information on the therapeutic development based on the Vaginitis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase ...  |  read more...
USD 1,250
Vasomotor Symptoms of Menopause-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Vasomotor Symptoms of Menopause. This report provides information on the therapeutic development based on the Vasomotor Symptoms of Menopause dealing with all the pipeline drugs, comparative ...  |  read more...
USD 1,250
Global Cervical Dilators Industry 2014 Market Research Report
11/20/2014 | published by: 9Dimen Research
... the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Cervical Dilators basic information including Cervical Dilators definition, classification, ...  |  read more...
USD 2,850
Women Infertility Global Clinical Trials Review, H2, 2014
11/17/2014 | published by: GlobalData
... information and data relating to the clinical trials on Women Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Ovarian Cancer-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Primary Dysmenorrhea-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Uncomplicated Cervical And Urethral Gonorrhea-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Vulvovaginal Candidiasis-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Women Infertility-API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. ...  |  read more...
USD 2,000
Cervical Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Primary Dysmenorrhea- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Vaginal Atrophy (Atrophic Vaginitis)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs ...  |  read more...
USD 2,000
Vulval Atrophy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Vulvovaginal Candidiasis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Female Sexual Dysfunction Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Menstrual Disorders Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
< prev 1    3  4  5  6  7  8  9  10